Sulfonamides and Trimethoprim

On this page

Intro & MOA - Folate Foes

  • Sulfonamides & Trimethoprim: Key synthetic antimicrobials. Bacteriostatic individually.
  • MOA: Synergistic sequential blockade of bacterial folic acid synthesis. Humans utilize pre-formed dietary folate, ensuring selective toxicity.
    • Sulfonamides (e.g., Sulfamethoxazole):
      • PABA (para-aminobenzoic acid) structural analogues.
      • Competitively inhibit bacterial Dihydropteroate Synthase.
      • Prevent PABA $\rightarrow$ Dihydropteroic acid.
    • Trimethoprim:
      • Potent inhibitor of bacterial Dihydrofolate Reductase (DHFR).
      • Prevents DHF (Dihydrofolic acid) $\rightarrow$ THF (Tetrahydrofolic acid - active form).
  • 📌 Mnemonic: Sulfa drugs Stop PABA at the Start; Trimethoprim Targets DHFR Downstream.

Folate synthesis pathway with Sulfonamide and Trimethoprim

⭐ Co-trimoxazole (TMP-SMX combination) exhibits synergistic bactericidal activity due to this dual blockade, broadening spectrum and reducing resistance development.

Pharmacokinetics - Dynamic Duo's Journey

  • Sulfonamides (e.g., Sulfamethoxazole - SMX):
    • Absorption: Good orally.
    • Distribution: Variable protein binding (↑drug interactions: bilirubin, warfarin); crosses placenta.
    • Metabolism: Hepatic acetylation (📌 Slow acetylators ↑toxicity; metabolite → crystalluria).
    • Excretion: Renal (filtration, secretion); adjust dose in renal failure.
  • Trimethoprim (TMP):
    • Absorption: Good orally.
    • Distribution: Wide; excellent tissue penetration (CSF, prostate); lipophilic.
    • Metabolism: Hepatic (minor).
    • Excretion: Renal (mostly unchanged); adjust dose in renal failure.
  • Co-trimoxazole (SMX + TMP):
    • Pharmacokinetic match: Similar $T_{1/2}$ (~10-12h) allows combined dosing.
    • Dosing SMX 5:TMP 1 → plasma conc. 20:1 for synergy.

    ⭐ Sulfonamides displace bilirubin from albumin → ↑risk of kernicterus in neonates.

Clinical Spectrum - Germ Warfare Gurus

Co-trimoxazole (TMP-SMX): A broad-spectrum agent. Key uses:

  • Urinary Tract Infections (UTIs): Uncomplicated & complicated.
  • Pneumocystis jirovecii Pneumonia (PJP):
    • Treatment: Drug of Choice (DOC).
    • Prophylaxis: Immunocompromised (e.g., HIV CD4 < 200/mm³).
  • Nocardiosis: DOC.
  • Toxoplasmosis: Alternative for cerebral toxo in AIDS.
  • Listeriosis: Alternative, especially if penicillin-allergic.
  • Others: Shigellosis, Salmonella (select cases), Stenotrophomonas maltophilia.

Other Sulfonamides/Related:

  • Sulfasalazine: IBD (UC, Crohn's), Rheumatoid Arthritis.
  • Silver sulfadiazine: Topical for burn infections.
  • Sulfacetamide: Ophthalmic for bacterial conjunctivitis.
  • Pyrimethamine-Sulfadoxine: Malaria (limited by resistance).

⭐ Co-trimoxazole is the Drug of Choice (DOC) for Pneumocystis jirovecii pneumonia (PJP) treatment/prophylaxis and Nocardiosis.

Adverse Effects & Cautions - The Watch-Out List

  • Hypersensitivity: Rashes, fever, photosensitivity. Severe: Stevens-Johnson Syndrome (SJS), TEN.
  • Crystalluria: (Sulfonamides) Prevent with hydration. Risk with older agents.
  • Hematologic:
    • Sulfonamides: Hemolytic anemia (G6PD deficiency), agranulocytosis.
    • Trimethoprim: Megaloblastic anemia (folate deficiency), leukopenia.
  • Kernicterus: (Sulfonamides) In newborns; bilirubin displacement from albumin.

    ⭐ Sulfonamides: Contraindicated in neonates (< 2 months) & late pregnancy due to kernicterus risk.

  • Trimethoprim Specific: Hyperkalemia (monitor K+), GI upset.
  • 📌 Mnemonic (SULFA ADRs): SJS, Skin, Solubility low (crystalluria), Serum albumin displacement, Anemia (G6PD).
  • Contraindications:
    • Infants < 2 months (Sulfonamides).
    • Pregnancy (Sulfonamides near term; Trimethoprim 1st trimester).
    • G6PD deficiency (Sulfonamides).
  • Drug Interactions (↑ effect of): Warfarin, Methotrexate, Phenytoin. (Sulfonylureas with Sulfonamides).

High‑Yield Points - ⚡ Biggest Takeaways

  • Sulfonamides (Dihydropteroate synthase inhibitor) & Trimethoprim (Dihydrofolate reductase inhibitor) cause sequential folate blockade.
  • Co-trimoxazole (TMP-SMX) treats UTIs, PJP, Nocardiosis, Toxoplasmosis.
  • Sulfonamide ADRs: Hypersensitivity, SJS, crystalluria, G6PD hemolysis, kernicterus.
  • Trimethoprim ADRs: Megaloblastic anemia, leukopenia, hyperkalemia.
  • Resistance: Altered enzymes, ↑PABA, ↓permeability.
  • Contraindications: Newborns, late pregnancy (kernicterus); G6PD deficiency (sulfonamides).
  • Key precaution: Hydration with sulfonamides to prevent crystalluria.

Practice Questions: Sulfonamides and Trimethoprim

Test your understanding with these related questions

HIV patient presented with diarrhea. On stool examination, acid-fast organisms (Isospora belli) were seen. What is the drug of choice in this patient?

1 of 5

Flashcards: Sulfonamides and Trimethoprim

1/10

The fluoroquinolones _____ and moxifloxacin can be used to treat Streptococcus pneumoniae, Haemophilus spp. (community-acquired pneumonia)

TAP TO REVEAL ANSWER

The fluoroquinolones _____ and moxifloxacin can be used to treat Streptococcus pneumoniae, Haemophilus spp. (community-acquired pneumonia)

levofloxacin

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial